Pandora Report 5.9.2025

by dkellogg97, posted in Pandora Report

Blurb

Biodefense MS Information Session

“Prospective students are invited to attend a information session to hear more about the Biodefense M.S. program offered at the Schar School. The online session will provide an overview of the program, as well as the application process, student experience and graduate outcomes. This session admissions will be led by the Graduate Admissions team.”

This session will take place on Tuesday, May 20 at 12 pm EDT. Register here.

UNAIDS to Slash Workforce

UNAIDS, the UN agency that fights HIV/AIDS globally, is set to cut its workforce by more than half in addition to moving many of its postings to cheaper locations. This is the result of drastic funding cuts from donors like the US as well as countries in Asia and Europe, according to the agency. UNAIDS warned previously that, unless support for its efforts are restored soon, more than six million more people could die from AIDS in the next four years, and an addition 2,000 people per day could be infected with HIV.

Genetic Study Finds SARS-CoV-2 Originated in Wildlife Trade

In a study published Wednesday (“The Recency and Geographical Origins of the Bat Viruses Ancestral to SARS-CoV and SARS-CoV-2“), researchers compared the evolution of SARS with that of COVID-19 nearly two decades later. They analyzed the genomes of both SARS-CoV-1 and SARS-CoV-2, in addition to nearly 250 related coronaviruses in bats and other mammals. They determined that fragments of the human SARS-CoVs share very recent common ancestors with bat viruses, that both SARS-CoV-1-like and SARS-CoV-2-like viruses have circulated in Asia for millennia, that recent ancestors of human SARS-CoV-s likely circulated in western China and northern Laos, and that these ancestors traveled unexpectedly fast to reach sites of human emergence. Importantly, the authors note that, “We find that the direct ancestors of SARS-CoV and SARS-CoV-2 are unlikely to have reached their respective sites of emergence via dispersal in the bat reservoir alone, supporting interactions with intermediate hosts through wildlife trade playing a role in zoonotic spillover.”

This research comes at a time when the current administration is treating the lab leak theory like a given. Last month, the White House created a new webpage called “Lab Leak: The True Origin of Covid 19” which is now the landing page for sites once dedicated to providing information about COVID-19 and access to COVID-19 test kits. The White House further described the lab leak theory as “confirmed” last Friday, using it as a justification to cut $18 billion to NIH in response to what it described as NIH’s “inability to prove that its grants to the Wuhan Institute of Virology were not complicit in such a possible leak.”

Further Reading:

Trump Issues EO Restricting Federal Funding for GoF Research

President Trump signed an executive order this week that promises greater transparency on gain of function research, worse penalties for scientists who violate federal rules and guidelines, and a ban on federal funding for GoF research in countries of concern, such as the PRC. The move has been praised by some who worry that GoF research could lead to outbreaks or even a pandemic. Donald Trump likes to claim that this is how the COVID-19 pandemic began. However, others worry that the Trump administration has used too broad and vague of a definition of GoF, leading to concern that it could trap important low risk studies in its wide net.

Science discussed the new EO with GMU Biodefense Graduate Program Director Gregory Koblentz, who explained that, given Trump’s willingness to use federal research funding as a weapon in other battles, the EO could cause substantial problems for legitimate pathogen research. He said, “There is a high likelihood that research institutions will simply curtail such research for fear of running afoul of poorly worded policies and regulations that would impose draconian penalties on the institution.” He later explained that it is unclear how many extra layers of review and oversight academic researchers and their institutions can even manage amid massive budget cuts.

Further Reading:

MilliporeSigma to Add Temporary Tariff Surcharges to Products Shipped to US

One of the largest suppliers of medical research products, MilliporeSigma, recently announced it will be adding a temporary tariff surcharge to any product orders it ships to the United States. MilliporeSigma has yet to release the exact percentage of the surcharge, nor indicate how long it may last. As one of the largest medical research suppliers, this decision will have strong impacts on many labs, pharmaceutical companies, and research institutions.

HHS to Invest Half a Billion Dollars in NIH Vaccine Project

HHS is reportedly planning to invest $500 million in a project it calls “Generation Gold Standard,” which will aim to develop a universal-vaccine technology to protect against multiple strains of viruses all at once. The catch? The administration plans to base this universal vaccine platform on a β-propiolactone-inactivated (BPL-inactivated) whole-virus approach. This is a method that requires killing whole viruses using BPL and then using these viruses in inactivated vaccines.

Not only is this an old approach, but the concept of a universal flu vaccine is also nothing new. This move has left some scientists concerned that HHS is putting all of its eggs into one basket that has yet to be particularly successful despite strong efforts. Furthermore, this investment in the BPL platform represents a massive shift away from federal investments in mRNA vaccines, which were at the core of the success of Operation Warp Speed.

In a press release, NIH Director Jay Bhattacharya said, “Generation Gold Standard is a paradigm shift…It extends vaccine protection beyond strain-specific limits and prepares for flu viral threats – not just today’s, but tomorrow’s as well – using traditional vaccine technology brought into the 21st century.”

Further Reading:

NIH Continued to Cut Research Grants Event After Judge Blocked Cuts

The NIH terminated $1.8 billion in grants in less than 40 days as part of the administration’s effort to shrink the federal government and its spending, targeting, among other things, studies related to gender identity and gender affirming care. NIH continued to terminate grants, it seems, despite a federal judge ordering the administration to stop cutting funding related to gender identity and the provision of gender affirming care. This preliminary injunction was created in response to the president’s executive order requiring NIH to terminate such funding. Lawyers for the federal government have claimed in court that the administration has complied with the judge’s order.

Reporting from ProPublica describes how the Washington attorney general alleges the Trump administration violated this court order. The article explains, “Nearly two weeks after the court’s preliminary injunction was issued, the National Institutes of Health’s then-acting head, Dr. Matthew J. Memoli, drafted a memo that details how the agency, in response to Trump’s executive orders, cut funding for research grants that “promote or inculcate gender ideology.” An internal spreadsheet of terminated NIH grants also references “gender ideology” and lists the number associated with Trump’s executive order as the reason for the termination of more than a half dozen research grants.”

As ProPublica notes, other documents that have been filed in the case raise concerns about the role of the Department of Government Efficiency and its limited authority, as it is supposed to mostly act as an advisory body. However, in depositions filed in the case, multiple NIH officials testified that DOGE itself is who gave directions in hundreds of NIH grant terminations. This, along with the administration apparently ignoring yet another court order, are deeply concerning beyond even the realm of NIH, casting further doubt on the administration’s willingness to be transparent and conduct its business legally.

Further Reading:

HICPAC Terminated, NIOSH Staff Laid Off

The administration has terminated a federal advisory committee that was tasked with issuing guidance on preventing the spread of infections in health care facilities. The Healthcare Infection Control Practices Advisory Committee (HIPAC) formerly created national standards for things like hand washing, mask wearing, and the isolating of sick patients that are followed by most US hospitals. It was reported last week that HICPAC members had begun receiving termination letters, and that the committee’s webpage had been archived.

The CDC delivered the news about the committee’s termination to members last Friday. In a letter obtained by the media, which committee members said CDC sent to them following a virtual meeting, it was revealed that the termination actually took effect on March 31, more than a month prior. While the committee’s webpage is still available but archived, many are concerned its recommendations will not be updated at all in the future, failing to evolve in response to things like new scientific developments or the spread of drug-resistant microbes.

Elsewhere in CDC, nearly all of the remaining staff of the National Institute of Occupational Health and Safety were laid off last week. This came after new requests for investigations of things like workplace health hazards and firefighter injuries stopped being accepted. NIOSH was formed by the same law that created OSHA. NIOSH produced research that drove OSHA’s regulations and enforcement, in addition to providing its own voluntary recommendations to employers.

In a needed dose of good news from CDC, the Epidemic Intelligence Service has been granted an exemption to hire its new class of fellows, avoiding a feared halving of its workforce.

Further Reading:

Kennedy Selects New Director for FDA’s Center for Biologics Evaluation and Research

Secretary Kennedy has selected Vinay Prasad, a hematologist-oncologist who has attracted attention for his criticism of public health policy on social media, to lead the FDA’s Center for Biologics Evaluation and Research. He will succeed Peter Marks, who abruptly resigned from the position in March, citing disagreements with Kennedy. Prasad has been a staunch critic of COVID-19 vaccine mandates for children, though he did describe the vaccines themselves as a “miraculous, life-saving advance.”

Further Reading:

Trump Nominates Casey Means for Surgeon General

The administration has pulled its nomination of former Fox News medical contributor Janette Nesheiwat to become the next surgeon general. This was reported on Wednesday, the day before Nesheiwat was set to appear before the Senate HELP committee to begin her confirmation process. Nesheiwat is a medical director at CityMD, an urgent care company operating in New York, and does still regularly contribute her opinions and insights to Fox News. She is also the sister-in-law of former national security advisor turned UN ambassador nominee, Mike Waltz.

Nesheiwat has previously misrepresented her educational and professional background, claiming on different occasions that she attended the University of Arkansas and other US institutions for medical school. She also has misrepresented herself as being “double board-certified” in family and emergency medicine, when she is only board certified in family medicine. She has also misrepresented her time spent in Army ROTC, at times implying that she completed the program and commissioned into the Army. The reality is that, while she did enroll in ROTC and attended the program’s advanced camp, she did not commission.

In reality, she quit ROTC and obtained her MD from the American University of the Caribbean School of Medicine, a private for-profit institution. The fact that Nesheiwat lied about this repeatedly does point to a much broader issue, which is the bias many in the US have against Caribbean medical school graduates. Many US students seeking to become physicians turn to these institutions for a variety of reasons, including struggling to gain admission to programs in the US. Graduating from the Caribbean as a US student puts them in a difficult position as they compete for US residency slots as international medical graduates.

These programs are not without their faults, including comparatively lax admissions, higher attrition rates, lower licensing exam pass rates, and poorer odds of matching into US residency slots. However, the reality is that there are many practicing physicians in the US who did attend these programs and have gone on to be very successful in their careers, helping countless patients. Efforts by pundits and media outlets to twist this conversation into a dogpile on those who attend these institutions is not necessary or helpful.

The fact that Nesheiwat lied about this and other elements of her background is much more troubling, as is the fact that she was ever considered for surgeon general. What is much worse, however, is the apparent sway political activist Laura Loomer has over the president. Multiple outlets have reported that Loomer urged the president to pick a new nominee, not just because Nesheiwat has been untruthful about her background, but also because she is pro-vaccine and praised the COVID-19 vaccines.

This takes us to Wednesday, when President Trump announced the nomination of Casey Means for surgeon general. Means graduated from Stanford University School of Medicine in 2014. However, she dropped out of her surgical residency in favor of practicing “functional medicine,” a type of alternative medicine that relies heavily on debunked or unproven interventions and treatments. Her medical license has been inactive since 2024. Instead, Means has been essentially working as a wellness influencer, publishing a book that decries “mainstream medicine” and going on to found a CGM company, Levels. She is also the sister of Calley Means, who is currently serving as a special government employee at HHS. This is in sharp contrast to surgeons general of the past, who held active medical licenses, completed their residencies, and had strong, relevant leadership experience.

The surgeon general leads the Public Health Service Commissioned Corps, a uniformed service that works across HHS, supports other government organizations like the Coast Guard, augments other federal, state, and local agencies when needed, and deploys both domestically and internationally to provide medical care during different kinds of disasters and emergencies and engage in health diplomacy. Thus, while many Americans no longer see the surgeon general as an especially important role, it is still important to have someone qualified in that role. Casey Means does not fit that bill, and she may not even be eligible for this role as the surgeon general is a vice admiral in the commissioned corps. Appointment to the corps requires physicians to have an active, unrestricted medical license.

While the administration may be able to maneuver Means around this requirement, she certainly is not out of the woods. Shortly after President Trump’s announcement of her nomination, she too became the target of Laura Loomer, with Loomer accusing Means of being a “Marxist tree hugger” while decrying her use of “shrooms as ‘plant medicine'”. The nomination of Means, an ally of RFK Jr., has also triggered infighting within the MAHA movement itself.

Further Reading:

“The Global North is Increasingly Unsafe for Global Health Meetings”

Shashika Bandara, Nhial Deng, and Madhukar Pai recently published this piece in The Lancet. They explain in their introduction, “American civil rights activist Maya Angelou once wrote, “prejudice is a burden that confuses the past, threatens the future, and renders the present inaccessible”.1 At a time of unprecedented nationalist and far-right politics in some countries, many people working in global health increasingly encounter an unsafe environment for meetings and conferences, especially those who are considered as others, such as citizens of the Global South, immigrants, refugees and Indigenous, LGBTQ+, and racialised minorities.”

“KFF Tracking Poll on Health Information and Trust: Vaccine Safety and Trust”

From KFF: “As the Trump administration attempts to overhaul many government health agencies, the latest KFF Tracking Poll on Health Information and Trust finds that partisans’ trust in these agencies as sources of reliable vaccine information has shifted from where it stood under the Biden administration with trust declining among Democrats and rising among Republicans. While Democrats remain more likely than Republicans to trust the U.S. Centers for Disease Control and Prevention (CDC) and U.S. Food and Drug Administration (FDA), the share of Republicans who have a “great deal” or “fair amount” of trust in these agencies to provide vaccine information has increased by about 10 percentage points from 2023. Concurrently, trust in these agencies as reliable sources of vaccine information has fallen among Democrats by double digits, including for the CDC (70% now v. 88% in 2023) and the FDA (67% v. 86%).”

Read more here.

“The Trump Administration’s Foreign Aid Review: Status of PEPFAR”

From KFF: “Starting on the first day of his second term, President Trump issued several executive actions that have fundamentally changed foreign assistance. These included: an executive order which called for a 90-day review of foreign aid; a subsequent “stop-work order” that froze all payments and services for work already underway; the dissolution of USAID, including the reduction of most staff and contractors; and the cancellation of most foreign assistance awards. Although a waiver to allow life-saving humanitarian assistance was issued, it has been limited to certain services only and difficult for program implementers to obtain. In addition, while there have been several legal challenges to these actions, there has been limited legal remedy to date. As a result, U.S. global health programs have been disrupted and, in some cases, ended. Recent changes to the Department of Health and Human Services, including proposed cuts and reorganization, are also likely to affect these programs. This fact sheet is part of a series on the status of U.S. global health programs.”

Read more here.

“The Evolution of United States Governance Policies for Research Using Pathogens with Enhanced Pandemic Potential”

Gerald Epstein recently published this article in Applied Biosafety: “Background: Prompted by publications in 2012 involving the enhancement of a highly virulent but poorly transmissible human pathogen to make it more transmissible, the research community and the U.S. government have implemented policies to oversee research involving enhanced pathogens that pose the risk of causing a pandemic.”

“Method: This article reviews the evolution of policies governing high consequence, government-funded research that has been called “gain-of-function-research-of-concern,” research with “enhanced potential pandemic pathogens” (ePPPs), and research with “pathogens with enhanced pandemic potential” (PEPPs). It analyzes features that these policies share and points out some of their shortcomings, challenges, and ambiguities.”

“Results: These policies, culminating in the 2024 United States Government Policy for Oversight of Dual-Use Research of Concern and Pathogens with Enhanced Pandemic Potential, all define a set of consequential research activities that trigger the need for additional high-level review, and they all set out principles that must be satisfied before the research can be funded.”

“Conclusion: The 2024 policy, like its predecessors, only applies to government-funded research. Extending it to cover privately funded research would require either new regulations under existing statutory authority or new legislation. Like its predecessors, the 2024 policy requires that the benefits of PEPP research justify its potential pandemic risk. Unlike its predecessors, however, the 2024 policy is missing an important principle that prevents construction of a pandemic pathogen that—were it not for its creation in the proposed research—would have little likelihood of ever causing an actual pandemic.”

“Syria’s Clandestine Chemical Arsenal: The Complete Dossier”

From the Middle East Forum: “This report represents the culmination of six years of clandestine intelligence gathering by the Middle East Forum’s network of sources within and adjacent to the Syrian regime’s chemical weapons program. From 2018 until the Assad regime’s downfall, our sources methodically assembled intelligence on Syria’s military-chemical manufacturing complex, revealing an intricate system designed to develop, produce, and deploy chemical and biological weapons while evading international scrutiny.”

“At the heart of this enterprise were two key components: Institute 6000 (formerly Branch 3000), the scientific and research division tasked with developing chemical agents, and Branch 450, the security apparatus responsible for transporting, securing, and deploying these weapons. Both operated under the umbrella of the Center for Scientific Studies and Research (CSSR), a nominally civilian institution that served as the regime’s primary vehicle for weapons development.”

“This report provides unprecedented detail on personnel, facilities, operational procedures, command structures, and evasion tactics employed by the Syrian regime to maintain its chemical weapons capability despite international prohibitions and inspections. The intelligence contained herein is based on firsthand accounts from regime insiders, intercepted communications, and documentary evidence collected at great personal risk by our sources.”

“The Middle East Forum’s investigation reveals a program far more sophisticated, resilient, and extensive than previously understood by the international community. The complete picture that emerges is one of systematic deception orchestrated at the highest levels of the Syrian government, with direct oversight from the Presidential Palace.”

NEW: Quo Vadis WHO?

From Brown Pandemic Center: “The World Health Organization (WHO) is in a moment of crisis. The decision by the US to withdraw from the organisation leaves the WHO with a deficit of about 15% of its total funding through the end of 2025 and 45% projected for 2026-27.”

“The current crisis is new, but it lays bare long-standing, untenable realities: The WHO is overly dependent on a single global superpower to function; The WHO is doing too many things, which comes at the cost of effectively carrying out its core, essential functions; Member states from low-middle-income countries are disproportionately dependent on the WHO to deliver essential healthcare.”

“To avoid falling into a new dependency trap, WHO Member States should consider the following questions: What are the core functions of the WHO that member states cannot lose without major negative consequences for their health status? What functions of the WHO are duplicative of work done by another UN or global institution? Which local institutions can be leveraged in each member state to fulfil roles currently carried out by the WHO?”

This event will take place on May 13 at 12 pm EDT. Learn more and register here.

NEW: Pandemic Readiness in an Uncertain World

From the Geneva Graduate Institute: “Based on lessons from the COVID-19 pandemic, The Independent Panel for Pandemic Preparedness and Response (The Independent Panel) recommended a package of evidence-based reforms as a blueprint for transforming global pandemic prevention, preparedness and response systems. Since delivering their main report, the Independent Panel Co-Chairs – Her Excellency Ellen Johnson Sirleaf and the Right Honourable Helen Clark – along with several members have continued to advocate for implementation of the package.”

“While some progress has been made since 2021, it has been uneven and insufficient, and today dangerous gaps remain in national, regional and global systems to prevent, prepare for, and respond to emerging infectious disease threats. Political leadership has waned to dangerously low levels. This year has been tumultuous, and the level of uncertainty presents wide-ranging consequences for achieving a world safe from the threat of another pandemic.”

“Yet despite the challenging geopolitical landscape, the World Health Organization (WHO) Member States have reached consensus on a proposal for a pandemic agreement, which will now be put to the 78th World Health Assembly for adoption. This is a critical moment, but leadership and continued action are needed to protect the world from pandemic threats.”

“Informed by four new policy briefs developed by The Independent Panel, this event will engage leaders and experts in an open conversation about the prospect of delivering pandemic preparedness and response reforms over the next 12-18 months, delving into global and regional challenges, barriers to progress, and potential levers for change.”

This hybrid event will take place on May 20, 12-2 pm CEST. Learn more and register here.

Biosecurity: A Priority in the Era of Pandemics and AI

From PAN: “The risks of new pandemic threats are compounding. Zoonotic spillover and uncontained outbreaks are well-known risks that are not yet well enough addressed. Today, focus must also turn to biosecurity and biosafety risks. Beyond naturally occurring infectious disease threats, the risks of a manmade pandemic — by accident or by design — must be mitigated.”

“Pandemic Action Network (PAN) and The Independent Panel for Pandemic Preparedness and Response will convene a public event, Biosecurity: A Priority in the Era of Pandemics and AI, on the sidelines of WHA78 to discuss opportunities and risks in our evolving global health, technological, and geopolitical landscape, and offer concrete next steps to prioritise biosecurity and biosafety efforts needed to keep the world safe and secure.”

This event will take place on May 21, 07.00-09.00 CET. Learn more and register here.

Assessing Research Security Efforts in Higher Education, A Workshop

“The National Academies of Sciences, Engineering, and Medicine cordially invites you to attend a workshop to consider potential measures of effectiveness and performance, and the data needed, to assess research security and protection efforts in higher education by a range of Federal agencies.”

“The workshop will be held on Thursday, May 22, 2025 from 9:00 AM to 4:00 PM U.S. Eastern and Friday, May 23, 2025 from 9:00 AM to 1:30 PM U.S. Eastern at the National Academy of Sciences Building, 2101 Constitution Avenue, NW, Washington, DC 20418.  A remote participation option is available.”

Learn more and register here.

International Pandemic Sciences Conference

“Representatives from academia, industry, civil society and policy are invited to gather in Oxford, UK, and online from 30 June – 1 July 2025 for the International Pandemic Sciences Conference 2025.”

“This year’s conference theme, Getting Ahead of the Curve, will explore how we can work together to predict, identify and control epidemic and pandemic threats globally. ”

“Over two days of plenary, parallel and networking sessions, stakeholders from different sectors and communities will have the opportunity to share ideas, experiences and strategies on prediction, early detection and control of pandemic threats. ”

“The International Pandemic Sciences Conference 2025 is hosted by the Pandemic Sciences Institute at the University of Oxford.”

Learn more, register, and submit abstracts here.

SBA.4 International Synthetic Biology and Biosecurity Conference in Africa

From SynBio Africa: “The SBA 4.0 conference will serve as a platform for fostering connections among industry, academia, community groups, and policymakers. It will showcase innovative applications of synthetic biology and AI, and highlight ongoing efforts in biomathematics, biomanufacturing, one-health, biosafety and biosecurity. It will also facilitate networking and information exchange. Key focus areas include tackling agriculture, health, environmental management, and industry challenges. In Africa, synthetic biology is poised to drive the national development agenda by promoting a sustainable bioeconomy, supporting health and agricultural systems, and aiding environmental conservation and restoration. This event will provide a vital opportunity for stakeholders to discuss and strategize the integration of synthetic biology innovations, address policy, legal frameworks, and communicate the benefits of the technology.”

This conference will take place July 23-25 in Kigali. Learn more and register here.

CTD-SPECTRE 2nd Annual Symposium 

“The CTD-SPECTRE Symposium on Tropical and Emerging Infectious Diseases for Clinicians and Translational Scientists 2025 offers a unique opportunity to connect with global experts, gain cutting-edge insights, and collaborate with peers dedicated to infectious disease research and treatment.”

“Taking place September 16 -19, 2025, at the historic Grand Galvez in Galveston, TX, this immersive symposium will unite clinicians, translational investigators, and trainees to explore the latest breakthroughs in tropical and emerging infectious diseases.”

Learn more and register here.

OPCW-The Hague Award 2025 Open for Nominations

“The Organisation for the Prohibition of Chemical Weapons (OPCW) in partnership with the City of The Hague has opened a call for nominations for the 2025 OPCW-The Hague Award. Full details of the eligibility criteria and requirements for nominations, as well as the online nomination form, are now available on the OPCW official website.”

Learn more about the award here.

WHO in Action – WHO Pandemic Fund Newsletter

The WHO recently created a newsletter providing updates on its Pandemic Fund and the projects it has in more than 70 countries focused on pandemic prevention, preparedness, and response activities. The first newsletter is available here and introduces the Pandemic Fund Navigator, shares stories from Bhutan, Kazakhstan, Mongolia, Sri Lanka, Togo, and Yemen, and more. Subscribe here.

SIPRI Researcher, Biological Weapons or Biological and Chemical Weapons, WMD

“SIPRI’s Armament and Disarmament Cluster is hiring a Researcher, with specific focus on biological weapons or biological and chemical weapons, to join the Weapons of Mass Destruction (WMD) Programme.”

“The Weapons of Mass Destruction (WMD) Programme at SIPRI seeks to contribute to the understanding of trends and developments pertaining to nuclear, chemical and biological weapons. It considers their implications for an increasingly complex security landscape and seeks to identify approaches to address the risks and challenges WMD pose. To this end, the Programme examines the political, institutional, legal and technical aspects of WMD governance, focusing on international efforts at arms control and disarmament, materials security and non-proliferation, and risk reduction.  Recent research in chemical and biological weapons at SIPRI focuses on strengthening global norms against chemical weapon use, risks at the convergence of biology and technology, and implications of dual-use research in the life sciences.”

Learn more and apply here by May 16.

NTI|bio Hiring Program Associate/Program Officer, Global Biological Policy and Programs

“NTI – a global security organization driving systemic solutions to nuclear, biological, and emerging technology threats imperiling humanity – is seeking a Program Associate/Program Officer (title to be determined based on candidate experience) to join the Global Biological Policy and Programs (NTI | bio) team.”

“This position reports to the Vice President, or other senior manager, of the NTI | bio team. This is a full-time hybrid position, working a minimum of three days per week in our Washington, DC office.”

“NTI | bio is focused on reducing catastrophic biological risks, and we are working toward this goal by strengthening biotechnology governance; bolstering biosecurity in countries around the world; strengthening international capabilities to uphold the norm against bioweapon development and use; driving progress in global health security; and building the biosecurity field.”

Learn more and apply here.

Leave a comment